Light Therapy for Cancer-Related Fatigue in (Non-)Hodgkin Lymphoma Survivors: Results of a Randomized Controlled Trial
Daniëlle E. J. Starreveld(The Netherlands Cancer Institute), Eveline M. A. Bleiker(Cancer Clinic), Jessie de Geus(The Netherlands Cancer Institute), Huub H. van Rossum(The Netherlands Cancer Institute), William H. Redd(Icahn School of Medicine at Mount Sinai), Jos A. Bosch(University of Mannheim), Flora E. van Leeuwen(The Netherlands Cancer Institute), Marie José Kersten(Hovon), Jacobien M. Kieffer(Norwegian Womens Public Health Association), Erik W.A. Marijt(Radboud University Nijmegen), Laurien Daniëls(Leiden University Medical Center), Sonia Ancoli‐Israel(University of California San Diego), G. Esther A. Habers(Leiden University), Josée M. Zijlstra(Amsterdam University Medical Centers), Lara H. Böhmer(Haga Hospital), Susan K. Lutgendorf(University of Iowa), Mirthe Lanfermeijer(The Netherlands Cancer Institute), Heiðdís Valdimarsdóttir(Reykjavík University), Catharina M. Korse(The Netherlands Cancer Institute), Eus J.W. Van Someren(Royal Netherlands Academy of Arts and Sciences), Dick Johan van Spronsen(Radboud University Nijmegen), Eva de Jongh(Albert Schweitzer Ziekenhuis), Margreet Houmes(Admiraal De Ruyter Ziekenhuis), Roel J. de Weijer(University Medical Center Utrecht), Cécile P.M. Janus(Erasmus MC Cancer Institute)
Cited by 26
Related Papers
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
|New England Journal of Medicine|2020|1.9k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
|New England Journal of Medicine|2018|1.4k
Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies
|JNCI Journal of the National Cancer Institute|2010|716